Skip to content

Effect of time interval on feeding tolerance in ICU patients

Comparing the effects of nasogastric feeding intervals on feeding tolerance in Intensive Care Unit patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014081718832N1
Enrollment
63
Registered
2015-05-16
Start date
2014-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: diarrhoea. Condition 2: regurgitation. Condition 3: high gastric residual volume. Functional diarrhoea Nausea and vomiting Other specified symptoms and signs involving the digestive system and abdomen

Interventions

Intervention 1: 1st group: enteral nutrition via bolus infusion every 2 hours with 200 ml volume of standard formula for 3 days. Intervention 2: 2nd group: enteral nutrition via Bolus infusion every 3
Prevention
1st group: enteral nutrition via bolus infusion every 2 hours with 200 ml volume of standard formula for 3 days
2nd group: enteral nutrition via Bolus infusion every 3 hours with 300 ml volume of Standard Formula for 3 days
3rd group: enteral nutrition via Bolus infusion every 4 hours with 400 ml volume of Standard Formula for 3 days

Sponsors

Hamedan university of medical science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients are eligible for inclusion if they: are nasogastric tube fed via Bolus infusion; =18 years of age; are expected to have an ICU length of stay (LOS) >3days; don’t have diabetic disease, renal /hepatic failure because they need special formulas such as diabetic formula, hepatic formula; patients who are not immunocompromised; don’t have gastrointestinal diseases or surgery during recent 6 weeks; don’t have drug abuse history; don’t use drugs that increase gastrointestinal motility; don’t have diarrhea before the study. Participants are excluded from the study if they: need gastrointestinal motility enhancing drugs; change of feeding methods or formula during study; have gastric residual volume more than 200 ml; have gastrointestinal complications by another reasons; die or transfer from ICU to another wards; be made NPO due to the diagnostic and therapeutic procedures

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Regurgitation. Timepoint: during 24 hours for 3 days. Method of measurement: inspection.;Dification. Timepoint: during 24 hours for 3 days. Method of measurement: inspection.;Gastric residul volume. Timepoint: every 4 hours during 3 days. Method of measurement: using 60 ml syring.

Secondary

MeasureTime frame
Pulse rate. Timepoint: every 3 hours. Method of measurement: monitoring system.;Systolic blood pressure. Timepoint: every 3 hours. Method of measurement: monitoring system.;Diastolic blood pressure. Timepoint: every 3 hours. Method of measurement: monitoring system.;Body temprature. Timepoint: every 3 hours. Method of measurement: Mercurial thermometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamaneh Sadeghi Hedayat

Hamedan university of Medical Science

s.sadeghihedayat@umsha.ac.ir+98 81 3038 0572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026